Akhil Rajendra Kurup

Clinical development of a CDK8/19 kinase inhibitor for acute myeloid leukemia

What is the Prognostic Relevance of Responses Less Than a CR to Initial AML Treatment?

Low-Dose Versus Standard-Dose Abiraterone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Multicenter Randomized Phase III Trial

Rare germline ETV6 variant associated with thrombocytopenia and acute leukemia

Who truly benefits from gilteritinib combinations in FLT3-mutated relapsed-refractory(R/R) AML: a Canadian single center analysis